FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileGlobal X - S&P Biotech ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
CURE.AX
Global X - S&P Biotech ETF ETF AnalysisComprehensive ETF analysis for Global X - S&P Biotech ETF (CURE.AX) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisCURE.AX
CURE.AX
Global X - S&P Biotech ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
CURE.AX
  1. Home
  2. Screener
  3. Global X - S&P Biotech ETFCURE.AXETF

Global X - S&P Biotech ETF

ETF
🇦🇺CURE.AX•ASX•Equity
Fund size (AUD)
$47.19M
Expense Ratio
0.45%
Holdings
0

Your view on CURE.AX

Global X - S&P Biotech ETF

ETFGlobal X
🇦🇺CURE.AX•ASX•Equity
Fund size (AUD)
$47.19M
Expense Ratio
0.45%
Holdings
0
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Global X - S&P Biotech ETF (CURE.AX) is an Equity fund from Global X, listed since 2018, with $47.2M in assets under management, a 0.45% expense ratio and a NAV of $73.28 AUD.

Overview for Global X - S&P Biotech ETF

Fund Type
ETF
Fund Issuer
Global X
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
November 8, 2018
Domicile
AU
Website
globalxetfs.com.au/funds/cure
Fund Type
ETF
Fund Issuer
Global X
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
November 8, 2018
Domicile
AU
Website
globalxetfs.com.au/funds/cure
Fund Type
ETF
Fund Issuer
Global X
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
November 8, 2018
Domicile
AU
Website
globalxetfs.com.au/funds/cure

About this fund

The Global X S&P Biotech ETF, identified by its ticker CURE, endeavors to replicate the overall financial performance, encompassing both capital gains and dividends, of the S&P Biotechnology Select Industry Index, before any management fees and operational costs are deducted.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.45%

Fund size

$47.19M

Fund Details

NAV$73.28 AUD
Average Volume2.1K
Inception DateNovember 8, 2018
Asset ClassEquity
Fund IssuerGlobal X
DomicileAU
ISINAU0000028110
NAV CurrencyAUD

Expense Ratio

0.45%

Assets Under Management

$47.19M

NAV

$73.28 AUD

Average Volume

2.1K

Inception Date

November 8, 2018

Asset Class

Equity

Fund Issuer

Global X

Domicile

AU

ISIN

AU0000028110

NAV Currency

AUD

Expense Ratio

0.45%

Assets Under Management

$47.19M

NAV

$73.28 AUD

Average Volume

2.1K

Inception Date

November 8, 2018

Asset Class

Equity

Fund Issuer

Global X

Domicile

AU

ISIN

AU0000028110

NAV Currency

AUD

Data last updated: Nov 19, 2026, 08:12 AM

Sectors

How the fund's assets are split across sectors.

2 sectors
  • 1Healthcare
    99.5%
  • 2Financial Services
    0.5%

Top sector

Healthcare

Top weight

99.5%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

157 positions
1MRNAMODERNA INC
2.31%
2TGTXTG THERAPEUTICS
1.87%
3BIIBBIOGEN INC
1.85%
4GILDGILEAD SCIENCES
1.80%
5REGNREGENERON PHARM
1.80%
6ABBVABBVIE INC
1.78%
7EXELEXELIXIS INC
1.78%
8SYRESPYRE THERAPEUTI
1.77%
9INSMINSMED INC
1.77%
10AMGNAMGEN INC
1.76%
11UTHRUNITED THERAPEUT
1.74%
12ORKAORUKA THERAPEUTI
1.68%
13BBIOBRIDGEBIO PHARMA
1.62%
14ALKSALKERMES PLC
1.60%
15NBIXNEUROCRINE BIOSC
1.59%

Concentration

Top 10 Weight18.48%
1MRNAMODERNA INC
2.31%
2TGTXTG THERAPEUTICS
1.87%
3BIIBBIOGEN INC
1.85%
4GILDGILEAD SCIENCES
1.80%
5REGNREGENERON PHARM
1.80%
6ABBVABBVIE INC
1.78%
7EXELEXELIXIS INC
1.78%
8SYRESPYRE THERAPEUTI
1.77%
9INSMINSMED INC
1.77%
10AMGNAMGEN INC
1.76%
11UTHRUNITED THERAPEUT
1.74%
12ORKAORUKA THERAPEUTI
1.68%
13BBIOBRIDGEBIO PHARMA
1.62%
14ALKSALKERMES PLC
1.60%
15NBIXNEUROCRINE BIOSC
1.59%

Top 10 Weight

18.48%

1MRNAMODERNA INC
2.31%$1.09M
2TGTXTG THERAPEUTICS
1.87%$881.6K
3BIIBBIOGEN INC
1.85%$870.9K
4GILDGILEAD SCIENCES
1.80%$849.2K
5REGNREGENERON PHARM
1.80%$847.9K
6ABBVABBVIE INC
1.78%$839.2K
7EXELEXELIXIS INC
1.78%$838.1K
8SYRESPYRE THERAPEUTI
1.77%$834.0K
9INSMINSMED INC
1.77%$832.9K
10AMGNAMGEN INC
1.76%$828.2K
11UTHRUNITED THERAPEUT
1.74%$819.5K
12ORKAORUKA THERAPEUTI
1.68%$791.9K
13BBIOBRIDGEBIO PHARMA
1.62%$763.1K
14ALKSALKERMES PLC
1.60%$755.4K
15NBIXNEUROCRINE BIOSC
1.59%$749.5K

Top 10 Weight

18.48%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on20 funds
FundAsset classExpense ratioAssetsHoldings
CURE.AXGlobal X - S&P Biotech ETFThis fundEquity0.45%$47M0

Comparable funds

  • BOND.AXState Street SPDR S&P/ASX iBoxx Australian Bond ETFFixed Income0.10%$53M0
  • CETF.AXVanEck - FTSE China A50 ETFEquity0.60%$32M50
  • EIGA.AXPerennial Income Generator Active ETFEquity0.80%$25M0
  • ETPMPD.AXGlobal X Physical Palladium StructuredCommodities0.49%$15M0
  • HGEN.AXGlobal X Hydrogen ETFEquity0.69%$33M0
  • MVOL.AXiShares Edge MSCI Australia Minimum Volatility ETFEquity0.30%$32M95
  • OZF.AXState Street SPDR S&P/ASX 200 Financials EX A-REIT ETFEquity0.34%$43M30
  • SSO.AXState Street SPDR S&P/ASX Small Ordinaries ETFEquity0.50%$24M205

More Global X ETFs

  • SOCLGlobal X - Social Media ETFEquity0.65%$80M50
  • SPFFGlobal X - SuperIncome Preferred ETFFixed Income0.48%$133M50
  • SRETGlobal X - SuperDividend REIT ETFEquity0.58%$202M31
  • TECH.AXGlobal X - Morningstar Global Technology ETFEquity0.45%$339M0
  • TTTX.TOGlobal X Innovative Bluechip Top 10 Index ETFEquity0.60%$7M0
  • TYLGGlobal X - Information Technology Covered Call & Growth ETFEquity0.64%$15M78
  • UBIL-U.TOGlobal X 0-3 Month U.S. T-Bill ETFCash & Cash Equivalents0.13%$603M0
  • UCSH-U.TOGlobal X USD High Interest Savings ETFCash & Cash Equivalents0.16%$157M0
  • URAGlobal X - Uranium ETFEquity0.69%$4.4B60
  • USCC-U.TOGlobal X S&P 500 Covered Call ETFEquity0.47%$413M0
  • USCC.TOGlobal X S&P 500 Covered Call ETFEquity0.47%$570M0
  • USCL.TOGlobal X Enhanced S&P 500 Covered Call ETFEquity1.49%$243M0
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.